JOURNAL ARTICLE

Ozempic Exposed the Cracks in the Body Positivity Movement.

  • Published In: Time.com, 2023. P. 7 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Mhloyi, Catherine 3 of 3

Abstract

The article discusses the rising popularity of Ozempic, a drug originally designed to manage type 2 diabetes, which is now being used for weight loss, highlighting the societal pressures surrounding body image and thinness. It critiques the commodification of the body positivity movement, originally rooted in political activism by fat Black women, and how it has shifted towards a focus on self-love, often sidelining the experiences of marginalized bodies. The author reflects on personal experiences with fatphobia and the need for a more radical approach to body positivity that emphasizes community and solidarity rather than individual self-acceptance. The piece ultimately calls for a reevaluation of the body positivity movement in light of the current trends promoting weight loss and fat elimination. [Extracted from the article]

Additional Information

  • Source:Time.com. 2023/03, p7
  • Document Type:Article
  • Subject Area:Social Sciences and Humanities
  • Publication Date:2023
  • ISSN:2476-2679
  • Accession Number:162631118
  • Copyright Statement:Copyright of Time.com is the property of TIME USA, LLC and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.